39 post-doc-material-science "https:" Fellowship positions at Northeastern University
Sort by
Refine Your Search
-
with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by
-
, field-based US medical science liaison and promotional review committee and will also have the opportunity to specialize in a preferred area of medical affairs for an elective rotation. The fellow will
-
investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy
-
prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA
-
of a Masters degree in a technical field or extensive government or industry experience. Significant professional experience in cybersecurity, healthcare technology, embedded systems, or related
-
medical review of materials to ensure scientific accuracy and compliance · Support the development of training materials and internal scientific resources for medical teams Qualifications • Doctor
-
, an environment, and a culture that just aren’t found together anywhere else. This is the right place for you if you’re curious, motivated by the future of technology, and want to be part of a unique and diverse
-
starting Fall 2026. The postdoctoral scholar will work directly with Dr. Idia Binitie Thurston, Professor of Public Health & Health Sciences and Applied Psychology; Affiliate Professor of Africana Studies
-
with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by
-
prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA